Vimarsana
Biggest News Aggregation in the World

Efficacy Response News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Efficacy Response. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Efficacy Response Today - Breaking & Trending Today

High testosterone levels in older men associated with greater risk of atrial fibrillation - Vimarsana News

High testosterone levels in older men associated with greater risk of atrial fibrillation

Researchers investigated whether higher endogenous testosterone levels increase atrial fibrillation (AF) risk among healthy older males.

Testosterone Replacement Therapy Does Not Prevent Diabetes - Renal and Urology News - Vimarsana News

Testosterone Replacement Therapy Does Not Prevent Diabetes - Renal and Urology News

Men with prediabetes and diabetes have a high prevalence of hypogonadism. A trial tested testosterone replacement therapy’s efficacy in preventing progression from prediabetes to diabetes in men.

Testosterone Replacement Therapy for Hypogonadism Improves Mood, Energy - Vimarsana News

Testosterone Replacement Therapy for Hypogonadism Improves Mood, Energy

Testosterone replacement therapy for hypogonadism was associated with improved mood and energy among participants with depressive symptoms.

Testosterone Replacement Therapy for Hypogonadism Improves Mood, Energy - Vimarsana News

Testosterone Replacement Therapy for Hypogonadism Improves Mood, Energy

Testosterone replacement therapy for hypogonadism was associated with improved mood and energy among participants with depressive symptoms.

Prostate Risks Similar for Testosterone Therapy and Placebo - Vimarsana News

Prostate Risks Similar for Testosterone Therapy and Placebo

For men with hypogonadism and low prostate cancer risk, TRT didn't increase the risk for prostate adverse events, said a new analysis likely to inform decision-making.